PHARMACOKINETICS
Clinical trials for PHARMACOKINETICS explained in plain language.
Never miss a new study
Get alerted when new PHARMACOKINETICS trials appear
Sign up with your email to follow new studies for PHARMACOKINETICS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cholesterol drug showdown: which version works best?
Knowledge-focused OngoingThis early-stage study compares two forms of the cholesterol-lowering drug evolocumab in 400 healthy adults aged 18 to 60. Participants receive a single injection of one version, and researchers measure how much drug gets into the blood and how long it stays. The goal is to see i…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: Amgen • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New lithium formula could mean fewer side effects for brain disorders
Knowledge-focused OngoingThis early-stage study tests a new crystallized form of lithium (AL001) against standard lithium carbonate in 6 healthy adults. Participants take each drug for 14 days and undergo MRIs and blood draws to compare how much lithium reaches the brain. The goal is to see if AL001 is s…
Matched conditions: PHARMACOKINETICS
Phase: PHASE1 • Sponsor: Alzamend Neuro, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC